[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Human Vaccine Adjuvants Market Report 2017

October 2017 | 95 pages | ID: U4CBBFCB8DDWEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Human Vaccine Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Human Vaccine Adjuvants in these regions, from 2012 to 2022 (forecast).
United States Human Vaccine Adjuvants market competition by top manufacturers/players, with Human Vaccine Adjuvants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GSK
  • CSL Limited
  • Brenntag Biosector
  • Seppic
  • SPI Pharma
  • Novavax
  • Avanti Polar Lipids
  • Aphios Corporation
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Oral
  • Subcutaneous
  • Intramuscular
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Vaccine Adjuvants for each application, including
  • Research Application
  • Commercial Application
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Human Vaccine Adjuvants Market Report 2017

1 HUMAN VACCINE ADJUVANTS OVERVIEW

1.1 Product Overview and Scope of Human Vaccine Adjuvants
1.2 Classification of Human Vaccine Adjuvants by Product Category
  1.2.1 United States Human Vaccine Adjuvants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Vaccine Adjuvants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Subcutaneous
  1.2.5 Intramuscular
  1.2.6 Other
1.3 United States Human Vaccine Adjuvants Market by Application/End Users
  1.3.1 United States Human Vaccine Adjuvants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Research Application
  1.3.3 Commercial Application
1.4 United States Human Vaccine Adjuvants Market by Region
  1.4.1 United States Human Vaccine Adjuvants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.3 Southwest Human Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.5 New England Human Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.6 The South Human Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Vaccine Adjuvants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Vaccine Adjuvants (2012-2022)
  1.5.1 United States Human Vaccine Adjuvants Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Vaccine Adjuvants Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN VACCINE ADJUVANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Vaccine Adjuvants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Vaccine Adjuvants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Vaccine Adjuvants Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Vaccine Adjuvants Market Competitive Situation and Trends
  2.4.1 United States Human Vaccine Adjuvants Market Concentration Rate
  2.4.2 United States Human Vaccine Adjuvants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN VACCINE ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Vaccine Adjuvants Sales and Market Share by Region (2012-2017)
3.2 United States Human Vaccine Adjuvants Revenue and Market Share by Region (2012-2017)
3.3 United States Human Vaccine Adjuvants Price by Region (2012-2017)

4 UNITED STATES HUMAN VACCINE ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Vaccine Adjuvants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
4.3 United States Human Vaccine Adjuvants Price by Type (2012-2017)
4.4 United States Human Vaccine Adjuvants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN VACCINE ADJUVANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Vaccine Adjuvants Sales and Market Share by Application (2012-2017)
5.2 United States Human Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN VACCINE ADJUVANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CSL Limited
  6.2.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CSL Limited Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Brenntag Biosector
  6.3.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Brenntag Biosector Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Seppic
  6.4.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Seppic Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 SPI Pharma
  6.5.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 SPI Pharma Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novavax
  6.6.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novavax Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Avanti Polar Lipids
  6.7.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Avanti Polar Lipids Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Aphios Corporation
  6.8.2 Human Vaccine Adjuvants Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Aphios Corporation Human Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 HUMAN VACCINE ADJUVANTS MANUFACTURING COST ANALYSIS

7.1 Human Vaccine Adjuvants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Vaccine Adjuvants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Vaccine Adjuvants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Vaccine Adjuvants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN VACCINE ADJUVANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Vaccine Adjuvants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Vaccine Adjuvants Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Vaccine Adjuvants Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Vaccine Adjuvants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Human Vaccine Adjuvants
Figure United States Human Vaccine Adjuvants Market Size (K Pcs) by Type (2012-2022)
Figure United States Human Vaccine Adjuvants Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Subcutaneous Product Picture
Figure Intramuscular Product Picture
Figure Other Product Picture
Figure United States Human Vaccine Adjuvants Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Human Vaccine Adjuvants by Application in 2016
Figure Research Application Examples
Table Key Downstream Customer in Research Application
Figure Commercial Application Examples
Table Key Downstream Customer in Commercial Application
Figure United States Human Vaccine Adjuvants Market Size (Million USD) by Region (2012-2022)
Figure The West Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Vaccine Adjuvants Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Vaccine Adjuvants Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Human Vaccine Adjuvants Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Human Vaccine Adjuvants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Vaccine Adjuvants Sales Share by Players/Suppliers
Figure 2017 United States Human Vaccine Adjuvants Sales Share by Players/Suppliers
Figure United States Human Vaccine Adjuvants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Vaccine Adjuvants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Vaccine Adjuvants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Vaccine Adjuvants Revenue Share by Players/Suppliers
Figure 2017 United States Human Vaccine Adjuvants Revenue Share by Players/Suppliers
Table United States Market Human Vaccine Adjuvants Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Vaccine Adjuvants Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Human Vaccine Adjuvants Market Share of Top 3 Players/Suppliers
Figure United States Human Vaccine Adjuvants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Vaccine Adjuvants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Vaccine Adjuvants Product Category
Table United States Human Vaccine Adjuvants Sales (K Pcs) by Region (2012-2017)
Table United States Human Vaccine Adjuvants Sales Share by Region (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Share by Region (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Market Share by Region in 2016
Table United States Human Vaccine Adjuvants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Vaccine Adjuvants Revenue Share by Region (2012-2017)
Figure United States Human Vaccine Adjuvants Revenue Market Share by Region (2012-2017)
Figure United States Human Vaccine Adjuvants Revenue Market Share by Region in 2016
Table United States Human Vaccine Adjuvants Price (USD/Pcs) by Region (2012-2017)
Table United States Human Vaccine Adjuvants Sales (K Pcs) by Type (2012-2017)
Table United States Human Vaccine Adjuvants Sales Share by Type (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Share by Type (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Market Share by Type in 2016
Table United States Human Vaccine Adjuvants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Vaccine Adjuvants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Vaccine Adjuvants by Type (2012-2017)
Figure Revenue Market Share of Human Vaccine Adjuvants by Type in 2016
Table United States Human Vaccine Adjuvants Price (USD/Pcs) by Types (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Growth Rate by Type (2012-2017)
Table United States Human Vaccine Adjuvants Sales (K Pcs) by Application (2012-2017)
Table United States Human Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Market Share by Application in 2016
Table United States Human Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
Figure United States Human Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure GSK Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure GSK Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Limited Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure CSL Limited Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure CSL Limited Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Brenntag Biosector Basic Information List
Table Brenntag Biosector Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Brenntag Biosector Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Brenntag Biosector Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Brenntag Biosector Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Seppic Basic Information List
Table Seppic Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Seppic Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Seppic Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Seppic Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table SPI Pharma Basic Information List
Table SPI Pharma Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SPI Pharma Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure SPI Pharma Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure SPI Pharma Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Novavax Basic Information List
Table Novavax Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novavax Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Novavax Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Novavax Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Avanti Polar Lipids Basic Information List
Table Avanti Polar Lipids Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Avanti Polar Lipids Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Avanti Polar Lipids Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Avanti Polar Lipids Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Aphios Corporation Basic Information List
Table Aphios Corporation Human Vaccine Adjuvants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aphios Corporation Human Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Aphios Corporation Human Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Aphios Corporation Human Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccine Adjuvants
Figure Manufacturing Process Analysis of Human Vaccine Adjuvants
Figure Human Vaccine Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccine Adjuvants Major Players/Suppliers in 2016
Table Major Buyers of Human Vaccine Adjuvants
Table Distributors/Traders List
Figure United States Human Vaccine Adjuvants Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccine Adjuvants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Vaccine Adjuvants Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Human Vaccine Adjuvants Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Human Vaccine Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Vaccine Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Vaccine Adjuvants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories